What is Pharmacogenomics (PGx) Testing? Pharmacogenomics (PGx) testing analyzes a person’s genetic profile to predict how they may respond to medications. While many drugs are prescribed using a “one-size-fits-all” approach, their effectiveness can vary significantly between individuals. What works well for one person may be ineffective or even harmful for another. This variability can be […]
Genetic Screening for Breast and Ovarian Cancer Susceptibility Understanding the risk of breast and ovarian cancer in women Breast and ovarian cancers are among the most common and serious health concerns for women. In the general population, women have approximately an 8% lifetime risk of developing breast cancer and a 2% risk of developing ovarian […]
1. Introduction to NIPT technology Non-Invasive Prenatal Testing (NIPT), utilizing advanced Next-Generation Sequencing (NGS) platforms and bioinformatics analysis, detects the risk of fetal chromosomal aneuploidies by sequencing and analyzing cell-free fetal DNA (cffDNA) extracted from the peripheral blood of pregnant women. Vangenes NIPT Basic screens for the risk of Down Syndrome (Trisomy 21), Edwards Syndrome […]